Latest news
Oculis acquires full rights to Privosegtor, boo... - PluangPluang · Mon, 10 Aug 2026 07:26:37 GMTOliX Hires RNAi Expert Min Ji-young as EVP to Boost Licensing - Seoul Economic DailySeoul Economic Daily · Mon, 10 Aug 2026 05:44:21 GMTOliX taps GSK veteran Min Ji-young to drive global RNAi development - CHOSUNBIZ - ChosunbizChosunbiz · Mon, 10 Aug 2026 04:28:00 GMTLatigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs - MedCity NewsMedCity News · Sun, 09 Aug 2026 22:02:34 GMTVKTX Stock Steady After-Hours On Positive Obesity Drug Pipeline Progress - StocktwitsStocktwits · Sat, 08 Aug 2026 10:01:00 GMTTranscenta sells CDMO assets to WuXi Bio to focus on drug pipeline - AllSciAllSci · Fri, 07 Aug 2026 13:23:56 GMTLatigo IPO raises nearly $350M for pain drug development - BioPharma DiveBioPharma Dive · Fri, 07 Aug 2026 13:05:46 GMTTNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - StocktwitsStocktwits · Fri, 07 Aug 2026 12:01:14 GMT